Brandy Martinez, PA
Medical · Costa Mesa, CANPI 1235875527
Payments from drug & device makers
Across 916 payments — averaging $21.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Johnson & Johnson$2K
- Otsuka America Pharmaceutical, Inc.$2K
- Neurocrine Biosciences, Inc.$2K
- Vanda Pharmaceuticals Inc.$2K
- plus $9K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 101 | $2,013 |
| Teva Pharmaceuticals USA, Inc. | 122 | $1,967 |
| Johnson & Johnson | 58 | $1,842 |
| Otsuka America Pharmaceutical, Inc. | 68 | $1,774 |
| Neurocrine Biosciences, Inc. | 63 | $1,598 |
| Vanda Pharmaceuticals Inc. | 63 | $1,597 |
| AbbVie | 62 | $1,522 |
| Lundbeck LLC | 80 | $1,282 |
| Axsome Therapeutics, Inc. | 31 | $747 |
| Corium, LLC | 32 | $724 |
| Alkermes, Inc. | 24 | $647 |
| Noven Therapeutics, LLC | 33 | $594 |
| Takeda Pharmaceuticals U.S.A., Inc. | 41 | $542 |
| Supernus Pharmaceuticals, Inc. | 16 | $530 |
| Indivior Inc. | 21 | $456 |
| E.r. Squibb & Sons, L.L.C. | 17 | $407 |
| Biogen | 10 | $258 |
| Ironshore Pharmaceuticals Inc. | 12 | $242 |
| Almatica Pharma LLC | 10 | $237 |
| Bausch Health US, LLC | 11 | $222 |
| Idorsia Pharmaceuticals US Inc | 9 | $155 |
| Braeburn Inc. | 6 | $129 |
| USWM, LLC | 9 | $126 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $89 |
| Avion Pharmaceuticals | 4 | $73 |
| Tris Pharma Inc | 3 | $47 |
| Azurity Pharmaceuticals, Inc. | 1 | $25 |
| Vertical Pharmaceuticals, LLC | 1 | $25 |
| Merck | 1 | $22 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Novo Nordisk | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
How this compares
$19,962 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Costa Mesa
- Jennifer SebastianCosta Mesa$30K
- Andrew JohnsonCosta Mesa$22K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.